ReviewSurvey of ophthalmology
Anterior segment optical coherence tomography in uveitis: A comprehensive review of clinical applications, diagnostic insights, and future directions.
Review in Survey of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lipemic anterior chamber mimicking uveitis in severe hypertriglyceridemia: a case report and literature review.BMC ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Anterior segment optical coherence tomography (AS-OCT) is emerging as an essential tool in the diagnosis and monitoring of uveitis. Offering noninvasive, high-resolution imaging, AS-OCT allows clinicians to visualize and quantify subtle changes in the anterior chamber (AC), iris, cornea, sclera, and lens that may be difficult to capture with slit-lamp examination alone. We highlight how AS-OCT improves the detection of AC cells and flare, supports disease monitoring through automated, reproducible metrics, and facilitates care in challenging settings, such as pediatric uveitis or clinical trials. In the cornea, AS-OCT allows detailed evaluation of keratic precipitates and subclinical endothelial dysfunction. It also provides disease-specific metrics of iris thickness and surface smoothness in conditions such as Fuchs uveitis syndrome. In the sclera, AS-OCT can distinguish episcleritis from scleritis, differentiate their subtypes, and monitor inflammation resolution. Emerging applications, including anterior vitreous imaging and artificial intelligence-driven analysis, suggest a growing role for AS-OCT in personalized care. As evidence expands, AS-OCT is poised to become a cornerstone of multimodal imaging in uveitis, enhancing precision, reducing subjectivity, and improving outcomes for patients across a wide spectrum of inflammatory eye disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.